VLON Vallon Pharmaceuticals, Inc.
Vallon Pharmaceuticals, Inc. engages in developing and manufacturing medicines for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy disorder. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
$0.28 +0.01 (4.52%)
As of 02/01/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 02/10/2021
Outstanding shares: 12,742,342
Average volume: 437,993
Market cap: $3,569,130
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol: BMZ4LK7
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 1.10
PS ratio: 0.00
Return on equity: -276.79%
Net income %: 0.00%